Basic Information
ID: ALA638978
Type: Functional
Description: phase 1 oral half life at a dose 200 mg. (200 mg provided >95% inhibition of ex vivo stimulated LTB4 in blood up to 18 hour post dose)
Tissue: Blood
Activity Charts
Bioactivity
Activity Types for Assay ALA638978
T1/2
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 609.17 | 9.01 | 9.01 |